These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Thyroid neoplasms of follicular cell derivation: a simplified approach. Asa SL; Mete O Semin Diagn Pathol; 2013 Aug; 30(3):178-85. PubMed ID: 24144287 [TBL] [Abstract][Full Text] [Related]
25. Pre-miR146a expression in follicular carcinomas of the thyroid. Roncati L; Pignatti E; Vighi E; Magnani E; Kara E; Rochira V; Carani C; Simoni M; Maiorana A Pathologica; 2014 Jun; 106(2):58-60. PubMed ID: 25291868 [TBL] [Abstract][Full Text] [Related]
26. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819 [TBL] [Abstract][Full Text] [Related]
27. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136 [TBL] [Abstract][Full Text] [Related]
28. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches. Baldan F; Mio C; Allegri L; Passon N; Lepore SM; Russo D; Damante G Minerva Endocrinol; 2018 Sep; 43(3):285-293. PubMed ID: 28880059 [TBL] [Abstract][Full Text] [Related]
30. The prognostic value of miRNA146a in follicular thyroid carcinoma. Roncati L; Simoni M; Maiorana A Med Oncol; 2013 Dec; 30(4):703. PubMed ID: 23982677 [No Abstract] [Full Text] [Related]
31. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting. Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418 [TBL] [Abstract][Full Text] [Related]
32. Follicular carcinoma thyroid in Pendred syndrome. Bashir EA; Ahmed S; Murtaza B; Abbasi MH; Shah SS; Tamimy MS; Awan AS J Coll Physicians Surg Pak; 2004 Nov; 14(11):679-80. PubMed ID: 15530279 [TBL] [Abstract][Full Text] [Related]
38. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Eszlinger M; Paschke R Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161 [TBL] [Abstract][Full Text] [Related]
39. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors. Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218 [TBL] [Abstract][Full Text] [Related]
40. [Management of patients with thyroid tumors; global trends, current status in Japan and clinical problems and questions]. Nakamura H Nihon Rinsho; 2007 Nov; 65(11):1937-42. PubMed ID: 18018552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]